Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C1orf56 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
mRNA | ABL1 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | GPR89A | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | ADAMTS14 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | MCL1 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
mRNA | RBM8A | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
mRNA | ENSA | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
mRNA | SCAF8 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
mRNA | HMBOX1 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-05 |
mRNA | BOLA2 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |